|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock based compensation | |||||
| Unrealized loss on investments | |||||
| Realized gain on sale of investments | |||||
| Changes in operating assets and liabilities, net of acquisition: | |||||
| Accounts receivable | |||||
| Deposits | |||||
| Prepaid expenses and other current assets | |||||
| Inventory | |||||
| Lease liability, net | |||||
| Accounts payable and accrued expenses | |||||
| Deferred tax asset | |||||
| Accounts payable and accrued expenses and other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment, intangibles and long-lived assets available for sale | |||||
| Purchase of investments | |||||
| Sale of investments | |||||
| Cash used for assets acquisition, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Payments on loans and obligations | |||||
| Proceeds from loan payable | |||||
| Repurchase of common stock | |||||
| Net Cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Initial recognition of right of use asset | |||||
| Common stock issued on conversion of notes payable | |||||
Loading...